

Here’s why organisations are bringing their teams to HBI 2023
With 40 informative sessions, over 100 expert speakers, and more than 14 hours dedicated to learning and networking, HBI 2023 is an event with countless
HBI delivers unique content on for-profit healthcare services in Europe and Emerging Markets. Our market intelligence focuses on investment and business strategies across twenty health and care sectors with exclusive news, data, analysis and events.
Studies have shown that organisations with higher digital maturity are almost three times more likely to generate growth and increase profit margins than less mature organisations. With increased competition, getting the digital experience wrong could be catastrophic for your brand.
With 40 informative sessions, over 100 expert speakers, and more than 14 hours dedicated to learning and networking, HBI 2023 is an event with countless
We’ve got some really interesting stuff now at HBI 2023, June 19-21. Chinta Bhagat of L Catterton is speaking on how wellness and health care are merging.
In 2022, no fewer than 144 investor delegates attended the HBI conference. No other single venue event can come close to that number. And they
After the largest all-cash MedTech acquisition of Varian Medical Systems by Siemens Healthineers in April 2021, HBI interviews Chris Toth, CEO of Varian, to discuss the deal and their future plans.
Reading reviews of a GP practice in London recently, the phrase “terrible customer service” was frequently used. Throw in the mix other complaints about calls
How important is fund size in healthcare and how big is too big? This is a question that was raised during the healthcare panel moderated
Today’s pursuit of robust, efficient, sustainable health systems centres around three words. Partner. Innovate. Build. And that’s why these are at the heart of the
Healthcare, like most other sectors is becoming increasingly consumerised brought on by an uptick in digital transformation rapidly progressed by the pandemic. Patients now expect
The latest report from global law firm McDermott Will & Emery looks at the international investment landscape in healthcare, and life sciences. HBI speaks to
We talk to Dr. Nick West, the Chief Medical Officer, Global Medical Affairs for Abbott’s Vascular business about the results from Beyond Intervention—a multi-year global research initiative that uncover the differing perspectives of the patient, the physician, and the healthcare leader.
Ahead of HBI 2022 next month, HBI caught up with Stéphane Pichon, founding managing partner, Your Care Consult and the chair of the Investing in
These elite organisations are the spearhead for medical research in Europe and the rich Middle East. They are also the places where complex conditions are diagnosed and